Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Intrinsic Value

The intrinsic value of one NZYM B stock under the Base Case scenario is 124.41 DKK. Compared to the current market price of 403 DKK, Novozymes A/S is Overvalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NZYM B Intrinsic Value
124.41 DKK
Overvaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novozymes A/S

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for NZYM B cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about NZYM B?
Bearish
Neutral
Bullish

Fundamental Analysis

403 DKK
-3.93%
-3.93%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Novozymes A/S
DK
Chemicals
Market Cap
165.6B DKK
IPO
May 27, 1905
Employees
6 184
Denmark
Market Cap
165.6B DKK
Industry
Chemicals
IPO
May 27, 1905
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Novozymes A/S

Provide an overview of the primary business activities
of Novozymes A/S.

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Summarize the latest earnings call
of Novozymes A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novozymes A/S.

Provide P/S
for Novozymes A/S.

Provide P/E
for Novozymes A/S.

Provide P/OCF
for Novozymes A/S.

Provide P/FCFE
for Novozymes A/S.

Provide P/B
for Novozymes A/S.

Provide EV/S
for Novozymes A/S.

Provide EV/GP
for Novozymes A/S.

Provide EV/EBITDA
for Novozymes A/S.

Provide EV/EBIT
for Novozymes A/S.

Provide EV/OCF
for Novozymes A/S.

Provide EV/FCFF
for Novozymes A/S.

Provide EV/IC
for Novozymes A/S.

Show me price targets
for Novozymes A/S made by professional analysts.

What are the Revenue projections
for Novozymes A/S?

How accurate were the past Revenue estimates
for Novozymes A/S?

What are the Net Income projections
for Novozymes A/S?

How accurate were the past Net Income estimates
for Novozymes A/S?

What are the EPS projections
for Novozymes A/S?

How accurate were the past EPS estimates
for Novozymes A/S?

What are the EBIT projections
for Novozymes A/S?

How accurate were the past EBIT estimates
for Novozymes A/S?

Compare the revenue forecasts
for Novozymes A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novozymes A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novozymes A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novozymes A/S compared to its peers.

Compare the P/E ratios
of Novozymes A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Novozymes A/S with its peers.

Analyze the financial leverage
of Novozymes A/S compared to its main competitors.

Show all profitability ratios
for Novozymes A/S.

Provide ROE
for Novozymes A/S.

Provide ROA
for Novozymes A/S.

Provide ROIC
for Novozymes A/S.

Provide ROCE
for Novozymes A/S.

Provide Gross Margin
for Novozymes A/S.

Provide Operating Margin
for Novozymes A/S.

Provide Net Margin
for Novozymes A/S.

Provide FCF Margin
for Novozymes A/S.

Show all solvency ratios
for Novozymes A/S.

Provide D/E Ratio
for Novozymes A/S.

Provide D/A Ratio
for Novozymes A/S.

Provide Interest Coverage Ratio
for Novozymes A/S.

Provide Altman Z-Score Ratio
for Novozymes A/S.

Provide Quick Ratio
for Novozymes A/S.

Provide Current Ratio
for Novozymes A/S.

Provide Cash Ratio
for Novozymes A/S.

What is the historical Revenue growth
over the last 5 years for Novozymes A/S?

What is the historical Net Income growth
over the last 5 years for Novozymes A/S?

What is the current Free Cash Flow
of Novozymes A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novozymes A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novozymes A/S

Current Assets 9.5B
Cash & Short-Term Investments 1.2B
Receivables 4.3B
Other Current Assets 4B
Non-Current Assets 18.9B
Long-Term Investments 267m
PP&E 12.3B
Intangibles 4.5B
Other Non-Current Assets 1.8B
Current Liabilities 7.3B
Accounts Payable 1.6B
Other Current Liabilities 5.6B
Non-Current Liabilities 7.2B
Long-Term Debt 4.6B
Other Non-Current Liabilities 2.6B
Efficiency

Earnings Waterfall
Novozymes A/S

Revenue
17.9B DKK
Cost of Revenue
-8.2B DKK
Gross Profit
9.7B DKK
Operating Expenses
-5.3B DKK
Operating Income
4.5B DKK
Other Expenses
-1.4B DKK
Net Income
3B DKK

Free Cash Flow Analysis
Novozymes A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NZYM B Profitability Score
Profitability Due Diligence

Novozymes A/S's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
63/100
Profitability
Score

Novozymes A/S's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

NZYM B Solvency Score
Solvency Due Diligence

Novozymes A/S's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
76/100
Solvency
Score

Novozymes A/S's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NZYM B Price Targets Summary
Novozymes A/S

There are no price targets for NZYM B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NZYM B?

Click here to dive deeper.

Dividends

Novozymes A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for NZYM B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

NZYM B News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one NZYM B stock?

The intrinsic value of one NZYM B stock under the Base Case scenario is 124.41 DKK.

Is NZYM B stock undervalued or overvalued?

Compared to the current market price of 403 DKK, Novozymes A/S is Overvalued by 69%.

Back to Top